BCAB
Price
$0.54
Change
+$0.04 (+8.00%)
Updated
Sep 5 closing price
Capitalization
31.5M
60 days until earnings call
ORMP
Price
$2.23
Change
+$0.01 (+0.45%)
Updated
Sep 5 closing price
Capitalization
91.44M
69 days until earnings call
Interact to see
Advertisement

BCAB vs ORMP

Header iconBCAB vs ORMP Comparison
Open Charts BCAB vs ORMPBanner chart's image
BioAtla
Price$0.54
Change+$0.04 (+8.00%)
Volume$994.23K
Capitalization31.5M
Oramed Pharmaceuticals
Price$2.23
Change+$0.01 (+0.45%)
Volume$58.88K
Capitalization91.44M
BCAB vs ORMP Comparison Chart in %
Loading...
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCAB vs. ORMP commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAB is a Buy and ORMP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BCAB: $0.54 vs. ORMP: $2.23)
Brand notoriety: BCAB and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAB: 140% vs. ORMP: 83%
Market capitalization -- BCAB: $31.5M vs. ORMP: $91.44M
BCAB [@Biotechnology] is valued at $31.5M. ORMP’s [@Biotechnology] market capitalization is $91.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAB’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • BCAB’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than BCAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAB’s TA Score shows that 6 TA indicator(s) are bullish while ORMP’s TA Score has 5 bullish TA indicator(s).

  • BCAB’s TA Score: 6 bullish, 4 bearish.
  • ORMP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both BCAB and ORMP are a good buy in the short-term.

Price Growth

BCAB (@Biotechnology) experienced а +17.78% price change this week, while ORMP (@Biotechnology) price change was +1.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

BCAB is expected to report earnings on Nov 05, 2025.

ORMP is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($91.4M) has a higher market cap than BCAB($31.5M). ORMP YTD gains are higher at: -7.851 vs. BCAB (-9.252). ORMP has higher annual earnings (EBITDA): -22.07M vs. BCAB (-63.02M). ORMP has more cash in the bank: 97.9M vs. BCAB (18.2M). ORMP has less debt than BCAB: ORMP (912K) vs BCAB (6.05M). BCAB has higher revenues than ORMP: BCAB (11M) vs ORMP (2M).
BCABORMPBCAB / ORMP
Capitalization31.5M91.4M34%
EBITDA-63.02M-22.07M286%
Gain YTD-9.252-7.851118%
P/E RatioN/A20.91-
Revenue11M2M550%
Total Cash18.2M97.9M19%
Total Debt6.05M912K663%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
47
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCABORMP
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPPMF0.170.01
+5.17%
Coppernico Metals Inc
FNCSF5.370.05
+0.94%
North American Financial 15 Split Corp
WHGRF1.07N/A
+0.10%
WH Group Ltd.
SRKE0.20N/A
N/A
Strake Inc.
VLEEF12.25N/A
N/A
Valeo SE

BCAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAB has been loosely correlated with KYMR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAB jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAB
1D Price
Change %
BCAB100%
+7.54%
KYMR - BCAB
38%
Loosely correlated
+3.10%
CTMX - BCAB
37%
Loosely correlated
+8.57%
NVO - BCAB
35%
Loosely correlated
-1.62%
GALT - BCAB
35%
Loosely correlated
-1.50%
DNLI - BCAB
34%
Loosely correlated
+4.33%
More

ORMP and

Correlation & Price change

A.I.dvisor tells us that ORMP and VALN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORMP and VALN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+0.45%
VALN - ORMP
29%
Poorly correlated
-2.15%
FULC - ORMP
28%
Poorly correlated
+11.34%
BCAB - ORMP
28%
Poorly correlated
+7.54%
PRLD - ORMP
27%
Poorly correlated
+7.89%
SONN - ORMP
27%
Poorly correlated
-1.72%
More